The Prevalence of Oral HPV Infection and Oral Lesions in People Living With HIV

Description

The study will evaluate 300 people living with HIV that attend the Vivent Clinic for HIV care. We will characterize our population and include age, race/ethnicity, sex at birth, tobacco use, alcohol use, other comorbidities, HPV vaccination status, other HPV disease, and lab values such as CD4 count and HIV viral load. We will compare results between participants who are HPV positive and negative. We will also evaluate the relationship between HPV oral infections and lesions and the variables above to better understand possible predictors of HPV infections and lesions.

Conditions

Human Immunodeficiency Virus, Human Papilloma Virus

Talk to us

Study Overview

On this page

Study Details

Study overview

The study will evaluate 300 people living with HIV that attend the Vivent Clinic for HIV care. We will characterize our population and include age, race/ethnicity, sex at birth, tobacco use, alcohol use, other comorbidities, HPV vaccination status, other HPV disease, and lab values such as CD4 count and HIV viral load. We will compare results between participants who are HPV positive and negative. We will also evaluate the relationship between HPV oral infections and lesions and the variables above to better understand possible predictors of HPV infections and lesions.

The Prevalence of Oral HPV Infection and Oral Lesions in People Living With HIV in a HIV Primary Care Clinic

The Prevalence of Oral HPV Infection and Oral Lesions in People Living With HIV

Condition
Human Immunodeficiency Virus
Intervention / Treatment

-

Contacts and Locations

Denver

Vivent Health, Denver, Colorado, United States, 80220

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Documented HIV test on any FDA-approved HIV test
  • 2. Ability and willingness of participant to provide informed consent
  • 3. Capable of performing an oral swish and spit sample collection
  • 4. Willingness to have an oral exam by Denver Vivent Health Dentist
  • 5. Has had at least two visits at the Vivent Health Denver clinic
  • 6. Study participant allows demographics and medical history/laboratory results in electronic medical records to be confidentially evaluated.
  • 1. Any medical or mental health diagnosis that the study team concludes would prohibits participation of the protocol
  • 2. CD4 count \< 200 cells/ml
  • 3. History of Oral/tongue cancer

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Vivent Health,

Study Record Dates

2024-09